most common treatment, colon cancer
Though the most common current treatment for colorectal cancer is surgical, there are currently four FDA-approved immunotherapiesâbevacizumab, cetuximab, ramucirumab, and panitumumabâall targeted antibodies. Furthermore, colorectal cancer is of the top cancer types for which immunotherapies are being evaluated.